Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Hydreight Technologies Inc (NURS) AI Stock Analysis

38 Followers
TSE:NURS

Hydreight Technologies Inc

(TSXV:NURS)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Negative Factors

Hydreight Technologies Inc (NURS) vs. iShares MSCI Canada ETF (EWC)

-60%-40%-20%0%20%40%TSE:NURS-35.98%EWC+21.04%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
CAD 169.06M
Dividend Yield
―
Average Volume (3M)
77.31K
Price to Earnings (P/E)
23.3
Beta (1Y)
0.87
Revenue Growth
323.84%
EPS Growth
―
Country
Canada
Employees
0
Sector
General
Sector Strength
55
Industry
Medical - Pharmaceuticals

Hydreight Technologies Inc Business Overview & Revenue Model

Company Description

Hydreight Technologies, Inc. is an e-script and telemedicine business-to-consumer (B2C) technology company, which engages in the business of connecting professional healthcare and wellness advisors (Advisors) to patients for the delivery of health an...

Hydreight Technologies Inc Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

TSE:NURS against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
TSE:AIDXTSE:AIDX54NeutralCAD 201.82M-10.05-14.21%―30.73%80.80%

* General Sector Average

Performance Comparison

-50%0%50%100%TSE:NURSTSE:EKGTSE:RHT.HTSE:AIDXTSE:KOVOTSE:CSPNDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
TSE:NURS and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
TSE:NURSHydreight Technologies Inc3.15-1.74-35.58%
TSE:EKGCardiocomm Solutions0.010.000.00%
TSE:RHT.HReliq Health Technologies0.210.000.00%
TSE:AIDXHealwell Ai Inc.0.60-0.48-44.44%
TSE:KOVOKovo HealthTech Corporation0.01-0.03-75.00%
TSE:CSPNCarespan Health Inc0.020.000.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.